ImageneBio Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

ImageneBio Stock Summary

ImageneBio competes with Connect Biopharma, InflaRx NV, Kalaris Therapeutics, Shattuck Labs, and Context Therapeutics. ImageneBio is entity of United States. It is traded as Stock on NASDAQ exchange.

ImageneBio Key Financial Ratios

ImageneBio Key Balance Sheet Accounts

ImageneBio Key Income Statement Accounts

ImageneBio Key Cash Accounts

ImageneBio Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ImageneBio's current stock value. Our valuation model uses many indicators to compare ImageneBio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ImageneBio competition to find correlations between indicators driving ImageneBio's intrinsic value. More Info.ImageneBio is rated third overall in operating margin category among its peers. It also is rated third overall in current valuation category among its peers . At present, ImageneBio's Operating Profit Margin is projected to increase significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ImageneBio's earnings, one of the primary drivers of an investment's value.

ImageneBio Systematic Risk

Today, most investors in ImageneBio Stock are looking for potential investment opportunities by analyzing not only static indicators but also various ImageneBio's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of ImageneBio growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of ImageneBio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ImageneBio. We use our internally-developed statistical techniques to arrive at the intrinsic value of ImageneBio based on widely used predictive technical indicators. In general, we focus on analyzing ImageneBio Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ImageneBio's daily price indicators and compare them against related drivers.

When running ImageneBio's price analysis, check to measure ImageneBio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImageneBio is operating at the current time. Most of ImageneBio's value examination focuses on studying past and present price action to predict the probability of ImageneBio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImageneBio's price. Additionally, you may evaluate how the addition of ImageneBio to your portfolios can decrease your overall portfolio volatility.